We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Valuation
Investment Thesis
SNS Laboratories Limited status is AMALGAMATED — merged into another entity. Zero revenue FY2017-18; net loss ₹4.57 Lakhs; no filings since 2018. MSEI listed (SNSLAB); authorized ₹5 Cr; paid-up ₹2.86 Cr. Office No. 322, 3rd Floor, S.S. Plaza, Mayfield Garden, Sector-47, Gurgaon 122001. CIN: L85110HR1985PLC022029.
Pros
Cons
Business Segments
Laboratories / Healthcare (Historical)
Laboratory services (NIC 85110 — healthcare); zero revenue FY2018; amalgamated — no independent operations. Gurgaon, Haryana.
Revenue Model
Historically: fee-for-service hospital and laboratory charges. No longer applicable post-amalgamation.
Detailed Analysis
Growth Plans
Strong healthcare demand in Gurgaon and Delhi NCR from large urban population
Government push for healthcare expansion under Ayushman Bharat scheme
Industry Tailwinds
Strong healthcare demand in Gurgaon and Delhi NCR from large urban population
Government push for healthcare expansion under Ayushman Bharat scheme
Recent Developments
SNS Laboratories Limited was amalgamated (merged) into another company. MCA status shows 'Amalgamated' with last balance sheet filed for March 2019.
Pre-2020Comparable Companies
LALPATHLAB · 18000 Cr
Frequently Asked Questions
About SNS Laboratories
SNS Laboratories Limited is a Gurgaon-based healthcare and laboratory services company incorporated in 1985, with CIN L85110HR1985PLC022029. The company is registered at S.S. Plaza Commercial Complex, Sector-47, Gurgaon, Haryana, and classified under hospital activities under MCA. Importantly, MCA records indicate that SNS Laboratories Limited has an 'Amalgamated' status, meaning the company has been merged into or combined with another entity. The last AGM was held on December 28, 2019, and the balance sheet was last filed for March 2019, suggesting the amalgamation or winding-down process was completed prior to 2020. Gurgaon (now Gurugram) is one of India's fastest-growing cities and a major healthcare hub, housing numerous hospitals, diagnostics labs, and medical centers. The company's address in Sector-47, Mayfield Garden area places it in a residential and commercial corridor with demand for local healthcare services. The directors listed for SNS Laboratories include Mehak Arora, Ram Sunder, Dharmendra Gupta, Ajay Kumar Sharma, and Sanjiv Kumar Sharma. Given the amalgamated status, the company's assets and liabilities would have been transferred to the acquiring entity, and it no longer operates as an independent business. SNS Laboratories represented one of the many small independent hospital and laboratory ventures that existed in Haryana before the large organized healthcare chains established dominant presence in the NCR region.
Key Milestones
Incorporated December 18, 1985 in Haryana (CIN: L85110HR1985PLC022029) — 40+ years old; Gurgaon
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Be the first to discuss SNS Laboratories — share your research, ask questions, or compare notes with other investors.
Industry Headwinds
Possible dormancy or very limited operations given share price at face value
Intense competition from well-capitalized hospital chains and diagnostic networks in Delhi NCR
MCA status shows 'Amalgamated' — company is no longer an independent operating entity; shares may have limited or no independent value
Source: Media Reports / Public Records
Share price at face value of ₹10 with no available financial disclosures raises concerns about current operational activity levels
Delhi NCR healthcare market is highly competitive with large private hospital chains (Fortis, Medanta, Max Healthcare) and major diagnostic chains
Hospital and laboratory services require compliance with Clinical Establishments Act, NABL accreditation, and various state health regulations
Healthcare infrastructure requires significant ongoing capital investment for equipment upgrades, skilled medical staff, and facility maintenance
FORTIS · 28000 Cr
METROPOLIS · 7000 Cr
MSEI listed (SNSLAB); zero revenue FY2018; net loss ₹4.57 Lakhs; authorized ₹5 Cr; paid-up ₹2.86 Cr
Status: AMALGAMATED — merged into another entity; no filings since 2018

Down Town Hospital
Healthcare
₹125
+0.00%